Could a simple scan prevent deadly liver failure after surgery?
NCT ID NCT07358975
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special imaging scan (Tc-GSA SPECT/CT) to see if it can predict liver failure after surgery for liver tumors. About 192 adults in Denmark will receive the scan before their operation. The goal is to compare this new method with standard tests and find the best way to identify high-risk patients, potentially improving surgical safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Technetium-99m galactosyl human serum albumin (Tc-GSA) injection
What this could lead to
If successful, this scan could help doctors better predict which patients are at risk of liver failure after surgery, leading to safer procedures and fewer complications.
What could go wrong
This is an early-phase study in a small group of patients in Denmark. The scan may not prove more accurate than existing tests, and results may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rigshospitalet
Copenhagen, 2100, Denmark
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••